On September 20, 2024, the U.S. Food and Drug Administration (FDA) approved the first influenza (flu) vaccine for at‑home use. The vaccine, ...

These are independent reviews of the products mentioned, but TIME receives a commission when purchases are made through affiliate links at no additional cost to the purchaser.

智通财经APP获悉，美国FDA批准了阿斯利康（AstraZeneca，AZN.US）旗下的无针鼻腔喷雾剂FluMist，用于预防2至49岁人群中由A型和B型流感病毒引起的流感疾病。FluMist成为首款可供符合条件的患者自行接种或由照护者接种的流感疫苗。 FluMist是一种减毒活疫苗，通过鼻 ...

FluMist is an efficacious and safely tolerated intranasal influenza vaccine. FluMist has gained approval from the FDA for self-administration by patients aged 18-49. FluMist is the first influenza ...

The FDA has approved the at-home use of FluMist, a nasal spray flu vaccine, available in fall 2025. Effective for healthy people aged 2 to 49, it offers a needle-free option but isn't suitable for ...

Now that the U.S. Food and Drug Administration has approved the at-home use of the flu vaccine spray FluMist, how do you know that it's the right choice for you and your family? One expert offers ...

Now that the U.S. Food and Drug Administration has approved the at-home use of the flu vaccine spray FluMist, how do you know ...